-
DiscoveryNovartis scientists target resistance threat in malaria
Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.
Discovery -
DiscoveryMutant protein spreads through a neural circuit in Huntington’s Disease
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
Discovery -
DiscoveryCancer cocktails come of age
Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.
Discovery -
DiscoveryCancer cocktails: LEE011 – a popular combination partner
Discovery -
DiscoveryCancer cocktails: LJM716 – closing a common release valve
Discovery -
DiscoveryCancer cocktails: ABL001 – hitting one target twice
Discovery -
DiscoveryCombination therapies: Seeking to block cancer’s pathways to growth
Talk to any cancer researcher or doctor today and what you hear is wonder and hope.
Discovery -
DiscoveryNovartis antibody increases muscle growth in mice and human cell cultures
An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.
Discovery -
DiscoveryTackling a rare disease: Working toward a treatment for SMA
Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
Discovery -
DiscoveryPhysician-Scientist Donald Ganem takes the reins in Infectious Disease
Discovery